Research
Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis
Bianca Hemmingsen, Jeppe B. Schroll, Jørn Wetterslev, Christian Gluud, Allan Vaag, David P. Sonne, Lars H. Lundstrøm and Thomas Almdal
September 09, 2014 2 (3) E162-E175; DOI: https://doi.org/10.9778/cmajo.20130073
Bianca Hemmingsen
1Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
MDPhDJeppe B. Schroll
2Nordic Cochrane Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
MDJørn Wetterslev
1Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
PhDChristian Gluud
1Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
DMScAllan Vaag
3Department of Endocrinology, Copenhagen University Hospital, Copenhagen, Denmark
DMScDavid P. Sonne
4Department of Internal Medicine, Copenhagen University Hospital Gentofte, University of Copenhagen, Hellerup, Denmark
PhDLars H. Lundstrøm
5Department of Anaesthesiology, Nordsjællands Hospital, Hillerød, Denmark
MDPhDThomas Almdal
4Department of Internal Medicine, Copenhagen University Hospital Gentofte, University of Copenhagen, Hellerup, Denmark
MDDMSc
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis
Bianca Hemmingsen, Jeppe B. Schroll, Jørn Wetterslev, Christian Gluud, Allan Vaag, David P. Sonne, Lars H. Lundstrøm, Thomas Almdal
Jul 2014, 2 (3) E162-E175; DOI: 10.9778/cmajo.20130073
Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis
Bianca Hemmingsen, Jeppe B. Schroll, Jørn Wetterslev, Christian Gluud, Allan Vaag, David P. Sonne, Lars H. Lundstrøm, Thomas Almdal
Jul 2014, 2 (3) E162-E175; DOI: 10.9778/cmajo.20130073
Related Articles
Cited By...
- Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study
- Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
- Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia
- Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study
- Some Doubts About the Mantra on the Deleterious Cardiovascular Effects of Sulfonylureas